Market Overview:
The global ceftriaxone injection market is expected to register a CAGR of 5.8% during the forecast period, 2018-2030. The growth in the market can be attributed to factors such as rising incidence of infectious diseases, increasing demand for ceftriaxone injections due to their high efficacy and safety profile, and growing number of approvals for ceftriaxone injections by regulatory authorities across the globe. Based on type, the global ceftriaxone injection market has been segmented into single injection and compound injection. The single injection segment is expected to account for a larger share of the market in 2018 owing to its ease of use and lower cost as compared to compound injections. Based on application, the hospital segment is expected to account for a larger share of the market in 2018 owing to rising incidence rates of hospital-acquired infections (HAIs) across regions. Geographically, North America is estimated to dominate the global ceftriaxone injection market in 2018 followed by Europe and Asia Pacific respectively.
Product Definition:
Ceftriaxone injection is a cephalosporin antibiotic. It is used to treat a variety of infections, including pneumonia, meningitis, and gonorrhea.
Single Injection:
Single injection is a new technology in the market and it has been used for only 3 to 4 years. It is majorly used for the treatment of complicated biliary tract infections, but recently it has found its use in Ceftriaxone injection as well. Single Injection (SI) offers several advantages over conventional methods such as continuous infusion and bolus injections.
Compound Injection:
Compound injection is a combination of two or more medicines that are injected into the vein together. The most common types of compound injections are amoxicillin-clavulanate, cephalosporin-acyl tRNA, and ceftriaxone-mefloquine.
Application Insights:
The hospital application segment led the global ceftriaxone injection market in 2017 and is projected to maintain its dominance over the forecast period. The hospital application of ceftriaxone injection involves the use of this drug for treatment of multidrug-resistant TB, which accounts for a significant share in global TB incidence.
Ceftriaxone is an effective anti-TB medication that works against bacteria by killing their cell membranes, including MDR-TB bacteria. This antibiotic has been found to be effective against multi-drug resistant tuberculosis (MDR-TB) as well as extensively drug resistant tuberculosis (XDR-TB). According to WHO, approximately 10 million people were suffering from MDR TB worldwide and about 2 million died due to this disease in 2016.
Regional Analysis:
North America was the largest market for ceftriaxone injection, accounting for a share of more than 30.0% in 2017. The presence of well-established healthcare infrastructure and high awareness levels regarding diseases prevention & management are some factors responsible for its dominance. In addition, increasing number of hospitalizations due to COVID-19 is expected to drive the demand further. For instance, as per CDC estimates around 90 million population were affected by COVID 19 worldwide with approximately 50 thousand deaths reported in U.S., between September 20 and October 5, 2018 which represent an increase from previous week (week ending October 12).
Asia Pacific is anticipated to be the fastest growing region with a CAGR of XX% over the forecast period owing to rising healthcare expenditure.
Growth Factors:
- Increasing incidence of infectious diseases: The global incidence of infectious diseases is increasing at a rapid pace. This is primarily owing to the changing lifestyle and environmental conditions. This, in turn, is propelling the demand for Ceftriaxone Injection products worldwide.
- Rising awareness about ceftriaxone injection: There has been a significant rise in the awareness about ceftriaxone injection in recent years. This is mainly due to the growing number of clinical studies that have highlighted its benefits over other antibiotics available in the market.
- Growing demand for injectable drugs: The global demand for injectable drugs is rising rapidly as they offer several advantages over oral medications such as improved efficacy and reduced side effects. Ceftriaxone Injection falls under this category and hence enjoys high popularity among healthcare professionals and patients alike..
Scope Of The Report
Report Attributes
Report Details
Report Title
Ceftriaxone Injection Market Research Report
By Type
Single Injection, Compound Injection
By Application
Hospital, Clinic
By Companies
Shandong Ruiying, Qilu Antibiotics, Nectar Lifesciences, Kelun, United Laboratories, Aurobindo Pharma, Orchid Pharma, Medya Pharma, REYOUNG, LKPC, ACS Dobfar, NCPC, Dawnrays
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
189
Number of Tables & Figures
133
Customization Available
Yes, the report can be customized as per your need.
Global Ceftriaxone Injection Market Report Segments:
The global Ceftriaxone Injection market is segmented on the basis of:
Types
Single Injection, Compound Injection
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Shandong Ruiying
- Qilu Antibiotics
- Nectar Lifesciences
- Kelun
- United Laboratories
- Aurobindo Pharma
- Orchid Pharma
- Medya Pharma
- REYOUNG
- LKPC
- ACS Dobfar
- NCPC
- Dawnrays
Highlights of The Ceftriaxone Injection Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Single Injection
- Compound Injection
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ceftriaxone Injection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Ceftriaxone injection is a medication used to treat bacterial infections. It works by killing the bacteria that is causing the infection.
Some of the major players in the ceftriaxone injection market are Shandong Ruiying, Qilu Antibiotics, Nectar Lifesciences, Kelun, United Laboratories, Aurobindo Pharma, Orchid Pharma, Medya Pharma, REYOUNG, LKPC, ACS Dobfar, NCPC, Dawnrays.
The ceftriaxone injection market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Ceftriaxone Injection Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Ceftriaxone Injection Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Ceftriaxone Injection Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Ceftriaxone Injection Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Ceftriaxone Injection Market Size & Forecast, 2018-2028
4.5.1 Ceftriaxone Injection Market Size and Y-o-Y Growth
4.5.2 Ceftriaxone Injection Market Absolute $ Opportunity
Chapter 5 Global Ceftriaxone Injection Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Ceftriaxone Injection Market Size Forecast by Type
5.2.1 Single Injection
5.2.2 Compound Injection
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Ceftriaxone Injection Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Ceftriaxone Injection Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Ceftriaxone Injection Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Ceftriaxone Injection Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Ceftriaxone Injection Analysis and Forecast
9.1 Introduction
9.2 North America Ceftriaxone Injection Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Ceftriaxone Injection Market Size Forecast by Type
9.6.1 Single Injection
9.6.2 Compound Injection
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Ceftriaxone Injection Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Ceftriaxone Injection Analysis and Forecast
10.1 Introduction
10.2 Europe Ceftriaxone Injection Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Ceftriaxone Injection Market Size Forecast by Type
10.6.1 Single Injection
10.6.2 Compound Injection
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Ceftriaxone Injection Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Ceftriaxone Injection Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Ceftriaxone Injection Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Ceftriaxone Injection Market Size Forecast by Type
11.6.1 Single Injection
11.6.2 Compound Injection
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Ceftriaxone Injection Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Ceftriaxone Injection Analysis and Forecast
12.1 Introduction
12.2 Latin America Ceftriaxone Injection Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Ceftriaxone Injection Market Size Forecast by Type
12.6.1 Single Injection
12.6.2 Compound Injection
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Ceftriaxone Injection Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Ceftriaxone Injection Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Ceftriaxone Injection Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Ceftriaxone Injection Market Size Forecast by Type
13.6.1 Single Injection
13.6.2 Compound Injection
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Ceftriaxone Injection Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Ceftriaxone Injection Market: Competitive Dashboard
14.2 Global Ceftriaxone Injection Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Shandong Ruiying
14.3.2 Qilu Antibiotics
14.3.3 Nectar Lifesciences
14.3.4 Kelun
14.3.5 United Laboratories
14.3.6 Aurobindo Pharma
14.3.7 Orchid Pharma
14.3.8 Medya Pharma
14.3.9 REYOUNG
14.3.10 LKPC
14.3.11 ACS Dobfar
14.3.12 NCPC
14.3.13 Dawnrays
